Cargando…

Effect of Prenatal Docosahexaenoic Acid Supplementation on Blood Pressure in Children With Overweight Condition or Obesity: A Secondary Analysis of a Randomized Clinical Trial

IMPORTANCE: The blood pressure–lowering property of docosahexaenoic acid (DHA) in children and adults is known, and an observational study from the Netherlands has linked higher intrauterine DHA exposure to lower childhood blood pressure. However, the association of prenatal intake of DHA supplement...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kerling, Elizabeth H., Hilton, Jamie M., Thodosoff, Jocelynn M., Wick, Jo, Colombo, John, Carlson, Susan E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2019
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484605/ https://www.ncbi.nlm.nih.gov/pubmed/30794304 http://dx.doi.org/10.1001/jamanetworkopen.2019.0088

Ejemplares similares

Dietary patterns of early childhood and maternal socioeconomic status in a unique prospective sample from a randomized controlled trial of Prenatal DHA Supplementation
por: Hidaka, Brandon H., et al.
Publicado: (2016)

Docosahexaenoic Acid-Rich Fish Oil Supplementation Reduces Kinase Associated with Insulin Resistance in Overweight and Obese Midlife Adults
por: Thota, Rohith N., et al.
Publicado: (2020)

Maternal Vitamin D Status and Infant Infection
por: Moukarzel, Sara, et al.
Publicado: (2018)

Prenatal Docosahexaenoic Acid Supplementation and Offspring Development at 18 Months: Randomized Controlled Trial
por: Ramakrishnan, Usha, et al.
Publicado: (2015)

Combination therapy with butyrate and docosahexaenoic acid for keloid fibrogenesis: an in vitro study
por: Torii, Kazuhiro, et al.
Publicado: (2017)

Prenatal Maternal Docosahexaenoic Acid (DHA) Supplementation and Newborn Anthropometry in India: Findings from DHANI
por: Khandelwal, Shweta, et al.
Publicado: (2021)

Association Between Enteral Supplementation With High-Dose Docosahexaenoic Acid and Risk of Bronchopulmonary Dysplasia in Preterm Infants: A Systematic Review and Meta-analysis
por: Marc, Isabelle, et al.
Publicado: (2023)

Prenatal docosahexaenoic acid effect on maternal-infant DHA-equilibrium and fetal neurodevelopment: a randomized clinical trial
por: Gustafson, Kathleen M., et al.
Publicado: (2021)

Effects of an Exercise Program on Cardiometabolic and Mental Health in Children With Overweight or Obesity: A Secondary Analysis of a Randomized Clinical Trial
por: Migueles, Jairo H., et al.
Publicado: (2023)

Higher dose docosahexaenoic acid supplementation during pregnancy and early preterm birth: A randomised, double-blind, adaptive-design superiority trial
por: Carlson, Susan E, et al.
Publicado: (2021)

Direct Dispensation of Prenatal Supplements With Iron and Anemia Among Pregnant People
por: Thiele, Lisa R., et al.
Publicado: (2023)

Prenatal exposure to glucocorticoids and the prevalence of overweight or obesity in childhood
por: Laugesen, Kristina, et al.
Publicado: (2022)

Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity
por: Ghusn, Wissam, et al.
Publicado: (2022)

Association of Overweight, Obesity, and Recent Weight Loss With Colorectal Cancer Risk
por: Mandic, Marko, et al.
Publicado: (2023)

Associations of Prenatal and Childhood Antibiotic Exposure With Obesity at Age 4 Years
por: Leong, Karen S. W., et al.
Publicado: (2020)

Arachidonic Acid and Docosahexaenoic Acid Metabolites in the Airways of Adults With Cystic Fibrosis: Effect of Docosahexaenoic Acid Supplementation
por: Teopompi, Elisabetta, et al.
Publicado: (2019)

Association of Docosahexaenoic Acid and Arachidonic Acid Serum Levels With Retinopathy of Prematurity in Preterm Infants
por: Hellström, Ann, et al.
Publicado: (2021)

Prenatal choline supplementation improves biomarkers of maternal docosahexaenoic acid (DHA) status among pregnant participants consuming supplemental DHA: a randomized controlled trial
por: Klatt, Kevin C, et al.
Publicado: (2022)

Weight control behaviors in overweight/obese U.S. adults with diagnosed hypertension and diabetes
por: Zhao, Guixiang, et al.
Publicado: (2009)

Several genetic polymorphisms interact with overweight/obesity to influence serum lipid levels
por: Yin, Rui-Xing, et al.
Publicado: (2012)

Time Trends and Sociodemographic Factors Associated With Overweight and Obesity in Children and Adolescents in Spain
por: de Bont, Jeroen, et al.
Publicado: (2020)

Consumption of Soft Drinks and Overweight and Obesity Among Adolescents in 107 Countries and Regions
por: Hu, Huan, et al.
Publicado: (2023)

NTproBNP in insulin-resistance mediated conditions: overweight/obesity, metabolic syndrome and diabetes. The population-based Casale Monferrato Study
por: Baldassarre, Stefano, et al.
Publicado: (2017)

Eicosapentaenoic and docosahexaenoic acid supplementation and inflammatory gene expression in the duodenum of obese patients with type 2 diabetes
por: Labonté, Marie-Ève, et al.
Publicado: (2013)

Comparison of neostigmine induced reversal of vecuronium in normal weight, overweight and obese female patients
por: Joshi, Shilpa Bhimasen, et al.
Publicado: (2015)

Sex-specific associations of fat mass and muscle mass with cardiovascular disease risk factors in adults with type 2 diabetes living with overweight and obesity: secondary analysis of the Look AHEAD trial
por: Terada, Tasuku, et al.
Publicado: (2022)

Effects of a Family-Based Lifestyle Intervention Plus Supervised Exercise Training on Abdominal Fat Depots in Children With Overweight or Obesity: A Secondary Analysis of a Nonrandomized Clinical Trial
por: Cadenas-Sanchez, Cristina, et al.
Publicado: (2022)

Effects of Docosahexaenoic Acid Supplementation on Blood Pressure, Heart Rate, and Serum Lipids in Scottish Men with Hypertension and Hypercholesterolemia
por: Sagara, Miki, et al.
Publicado: (2011)

Pharmacokinetics and Oxidation Parameters in Volunteers Supplemented with Microencapsulated Docosahexaenoic Acid
por: Petyaev, Ivan M, et al.
Publicado: (2018)

Overweight and obesity as protective factors against mortality in nonischemic cardiomyopathy patients with an implantable cardioverter defibrillator
por: Zhou, Bin, et al.
Publicado: (2020)

Plasma Imidazole Propionate Is Positively Correlated with Blood Pressure in Overweight and Obese Humans
por: van Son, Jamie, et al.
Publicado: (2021)

Association of Metabolically Healthy Overweight Phenotype With Abnormalities of Glucose Levels and Blood Pressure Among Chinese Adults
por: Xu, Renying, et al.
Publicado: (2019)

Maternal Docosahexaenoic Acid Exposure Needed to Achieve Maternal–Newborn EQ
por: Christifano, Danielle N., et al.
Publicado: (2022)

Association Between Maternal Exposure to Lead, Maternal Folate Status, and Intergenerational Risk of Childhood Overweight and Obesity
por: Wang, Guoying, et al.
Publicado: (2019)

Probability of 5% or Greater Weight Loss or BMI Reduction to Healthy Weight Among Adults With Overweight or Obesity
por: Kompaniyets, Lyudmyla, et al.
Publicado: (2023)

Mediation Analysis to Untangle Opposing Associations of High-Dose Docosahexaenoic Acid With IQ and Bronchopulmonary Dysplasia in Children Born Preterm
por: Sullivan, Thomas R., et al.
Publicado: (2023)

Association of Medicaid vs Marketplace Eligibility on Maternal Coverage and Access With Prenatal and Postpartum Care
por: Eliason, Erica L., et al.
Publicado: (2021)

Group vs Individual Prenatal Care and Gestational Diabetes Outcomes: A Secondary Analysis of a Randomized Clinical Trial
por: Chen, Yixin, et al.
Publicado: (2023)

Effect of Vitamin D(3) Supplements on Development of Advanced Cancer: A Secondary Analysis of the VITAL Randomized Clinical Trial
por: Chandler, Paulette D., et al.
Publicado: (2020)

Ethnic differences in cardiometabolic risk profile in an overweight/obese paediatric cohort in the Netherlands: a cross-sectional study
por: van Vliet, Mariska, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_r0ceoi9g5nkcv047j2oa8dkis4